Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Thromboembolic Complications in Beta Thalassemia major

Thromboembolic Complications in Beta Thalassemia major Thromboembolic complications in β-thalassemia major have seldom been reported and their association with risk factors such as left ventricular failure and postsplenectomy thrombocytosis has remained speculative. In this report we describe 4 patients with unusual thromboembolic manifestations: recurrent arterial occlusion, recurrent pulmonary thromboembolism, venous thrombosis and a fatal cerebrovascular event. Although in all patients both risk factors were present, the precise causes for their thromboembolic complications were not identified. In 1 patient, however, a marked increase in hematocrit following blood transfusion resulted, in all likelihood, in a fatal cerebrovascular infarction. We suspect that these patients (constituting 4% of our β-thalassemic group) represent a subset of those with high susceptibility to both arterial and venous thromboembolic complications. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Acta Haematologica Karger

Thromboembolic Complications in Beta Thalassemia major

Loading next page...
 
/lp/karger/thromboembolic-complications-in-beta-thalassemia-major-TmbnV2G6ym

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Karger
Copyright
© 1992 S. Karger AG, Basel
ISSN
0001-5792
eISSN
1421-9662
DOI
10.1159/000204720
Publisher site
See Article on Publisher Site

Abstract

Thromboembolic complications in β-thalassemia major have seldom been reported and their association with risk factors such as left ventricular failure and postsplenectomy thrombocytosis has remained speculative. In this report we describe 4 patients with unusual thromboembolic manifestations: recurrent arterial occlusion, recurrent pulmonary thromboembolism, venous thrombosis and a fatal cerebrovascular event. Although in all patients both risk factors were present, the precise causes for their thromboembolic complications were not identified. In 1 patient, however, a marked increase in hematocrit following blood transfusion resulted, in all likelihood, in a fatal cerebrovascular infarction. We suspect that these patients (constituting 4% of our β-thalassemic group) represent a subset of those with high susceptibility to both arterial and venous thromboembolic complications.

Journal

Acta HaematologicaKarger

Published: Jan 1, 1992

Keywords: β-Thalassemia; Deep vein thrombosis; Embolism, arterial and pulmonary; Thrombocytosis

There are no references for this article.